KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Non-cash Items (2016 - 2017)

Historic Non-cash Items for Emergent BioSolutions (EBS) over the last 7 years, with Q3 2017 value amounting to $38.0 million.

  • Emergent BioSolutions' Non-cash Items changed N/A to $38.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was $38.0 million, marking a year-over-year change of. This contributed to the annual value of $20.0 million for FY2015, which is 90338.09% up from last year.
  • According to the latest figures from Q3 2017, Emergent BioSolutions' Non-cash Items is $38.0 million.
  • Emergent BioSolutions' 5-year Non-cash Items high stood at $40.4 million for Q2 2015, and its period low was $1.5 million during Q2 2016.
  • Over the past 5 years, Emergent BioSolutions' median Non-cash Items value was $20.0 million (recorded in 2015), while the average stood at $16.4 million.
  • In the last 5 years, Emergent BioSolutions' Non-cash Items soared by 99031.29% in 2015 and then plummeted by 9633.52% in 2016.
  • Quarter analysis of 5 years shows Emergent BioSolutions' Non-cash Items stood at $23.1 million in 2013, then increased by 26.06% to $29.2 million in 2014, then crashed by 31.46% to $20.0 million in 2015, then plummeted by 92.6% to $1.5 million in 2016, then soared by 2467.83% to $38.0 million in 2017.
  • Its last three reported values are $38.0 million in Q3 2017, $1.5 million for Q2 2016, and $2.0 million during Q1 2016.